Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Ligand Pharma (LGND) Stock Price & Analysis
689 Followers
LGND Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$49.43 - $85.70
Previous Close$59.08
Volume64.35K
Average Volume (3M)93.87K
Market Cap
$1.03B
Enterprise ValueN/A
Total Cash (Recent Filing)$219.04M
Total Debt (Recent Filing)$11.67M
Price to Earnings (P/E)40.7
Beta1.35
Next Earnings
Nov 07, 2023EPS Estimate
$0.59Last Dividend Ex-Date
Nov 02, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)1.45
Shares Outstanding17,355,257
10 Day Avg. Volume126,655
30 Day Avg. Volume93,872
Standard Deviation0.17
R-Squared0.11
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)4.38
Price to Sales (P/S)38.89
Price to Cash Flow (P/CF)-3126.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$116.33Price Target Upside97.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Ligand Pharma News
Pre-EarningsIs LGND a Buy, Before Earnings?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LGND FAQ
What was Ligand Pharma’s price range in the past 12 months?
Ligand Pharma lowest stock price was $49.43 and its highest was $85.70 in the past 12 months.
What is Ligand Pharma’s market cap?
Currently, no data Available
When is Ligand Pharma’s upcoming earnings report date?
Ligand Pharma’s upcoming earnings report date is Nov 07, 2023 which is in 42 days.
How were Ligand Pharma’s earnings last quarter?
Ligand Pharma released its earnings results on Aug 08, 2023. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $0.636 by $0.784.
Is Ligand Pharma overvalued?
According to Wall Street analysts Ligand Pharma’s price is currently Undervalued.
Does Ligand Pharma pay dividends?
Ligand Pharma pays a Notavailable dividend of $30.01 which represents an annual dividend yield of N/A. See more information on Ligand Pharma dividends here
What is Ligand Pharma’s EPS estimate?
Ligand Pharma’s EPS estimate is $0.59.
How many shares outstanding does Ligand Pharma have?
Ligand Pharma has 17,355,257 shares outstanding.
What happened to Ligand Pharma’s price movement after its last earnings report?
Ligand Pharma reported an EPS of $1.42 in its last earnings report, beating expectations of $0.636. Following the earnings report the stock price went up 5.348%.
Which hedge fund is a major shareholder of Ligand Pharma?
Among the largest hedge funds holding Ligand Pharma’s share is Fisher Asset Management LLC. It holds Ligand Pharma’s shares valued at 3M.
---
Ligand Pharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$116.33 (97.64% Upside)
$116.33 (97.64% Upside)
Blogger Sentiment
Bullish
LGND Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 7.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $237.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.34%
12-Months-Change
Fundamentals
Return on Equity
4.33%
Trailing 12-Months
Asset Growth
-29.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ligand Pharma
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding LGND
Vanguard Total Stock Market ETF
$32.59M
Vanguard Health Care ETF
$3.75M
Vanguard Russell 3000 ETF
$68.40K
SPDR S&P 1500 Value Tilt ETF
$3.03K
Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
$80.06
Up to five ETFs with an Outperform Smart Score that hold LGND. The ETFs are listed according to market value of LGND within the ETF
Acer Therapeutics
―
Cyclacel Pharmaceuticals
―
Ovid Therapeutics
―
Moleculin Biotech
―
---